Navigation Links
Genomind to Participate in National Alliance on Mental Illness (NAMI) 2012 National Convention
Date:6/28/2012

Chalfont, PA (PRWEB) June 28, 2012

Genomind will demonstrate support for the millions of Americans affected by mental illness by participating in the National Alliance on Mental Illness (NAMI) 2012 National Convention. This marks the second year Genomind is appearing at NAMI; last year the company gave a presentation on emerging technologies in mental health.

The theme of this year’s meeting is “Think, Learn and Live: Wellness, Resiliency and Recovery.” It is a message that resonates with Genomind since the company was founded with the ultimate goal of improving patients’ lives - particularly the lives of patients with difficult-to-treat psychiatric conditions. Its core product, the Genecept™ Assay, is a simple to use, saliva-based tool to inform clinician treatment decision-making for a range of psychiatric disorders, including depression, bipolar disorder, schizophrenia, anxiety disorders, OCD and ADHD.

“We are proud to support NAMI,” said Dr. Jay Lombard, chief scientific officer and co-founder of Genomind. “It is a wonderful organization that is devoted to helping improve the lives of the over 1 in 4 adults and 1 in 10 children across America affected by mental illness. We share NAMI’s commitment to bringing advancements in research to clinical practice and patients.”

The convention will be held at the Sheraton Seattle from June 27-30. Genomind will exhibit the Genecept Assay in Booth 206. For more information about this year’s convention, please visit http://www.nami.org/template.cfm?section=convention.

About NAMI
NAMI is the nation's largest grassroots mental health organization dedicated to building better lives for the millions of Americans affected by mental illness. NAMI advocates for access to services, treatment, supports and research and is steadfast in its commitment to raising awareness and building a community of hope. For more information, please visit http://www.nami.org/.

About Genomind
Genomind is a personalized medicine company, comprised of innovative researchers and expert leaders in psychiatry and neurology. Genomind is committed to discovery of the underlying causes of neuropsychiatric disorders and supports the development of personalized medicine that improves patients’ lives. Genomind was founded by Ronald I. Dozoretz, MD, a psychiatrist who has devoted his career to improving mental health. Jay Lombard, DO, a neurologist and co-founder of Genomind, is a critically acclaimed author and nationally recognized thought leader in neuropsychiatry practice and research. Learn more at http://www.genomind.com.

Read the full story at http://www.prweb.com/releases/2012/6/prweb9650703.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Medical Experts Who Participated in CSL Behrings Key Issues Dialogue Prefer Albumin for Fluid Management
2. Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference
3. ViroPharma to Participate in Two December Healthcare Investor Conferences
4. National Defense Industrial Association's (NDIA) 2012 Biosurveillance Conference To Feature Keynote Speaker Laurie Garrett, Pulitzer Prize Winner and Bestselling Author
5. DOE-CEA Partnership Awards Mentoring Services to Finalists in National Clean Energy Business Plan Competition
6. International Probiotics Association Excited To Learn The FDA Has Decided To Issue A New, Revised NDI Draft Guidance
7. National Defense Industrial Association (NDIA) Opens Registration For 2012 Biosurveillance Conference, Set For August 27-28 in Washington, D.C.
8. Promoting the States Quality of Life, New Jersey Symphony Orchestra to Perform at BIO International Convention
9. International Survey of T2* Cardiovascular Magnetic Resonance in Thalassemia
10. Fortis Vice President of Nursing Robert Anders Named Academy of Nursing Education Fellow by National League for Nursing
11. OrthoAccel Technologies, Inc. Names U.S. National Sales Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... They call it the “hairy ball.” ... depiction of a system of linkages and connections so complex and dense that ... computer science at Worcester Polytechnic Institute (WPI) and director of the university’s bioinformatics ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... Lithuania, announced today that they have entered into a multiyear collaboration to identify ... CRISPR researchers with additional tools for gene editing across all applications. , Under ...
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces ... addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US Market ... hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. BioMedGPS ...
(Date:10/12/2017)... Diego, CA (PRWEB) , ... ... ... (https://www.onramp.bio/ ) has launched Rosalind™, the first-ever genomics analysis platform specifically ... all bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who ...
Breaking Biology Technology:
(Date:4/13/2017)... 13, 2017 According to a new market research ... Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and ... is expected to grow from USD 14.30 Billion in 2017 to USD ... 17.3%. ... MarketsandMarkets Logo ...
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 30.37% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
Breaking Biology News(10 mins):